Englese Thomas 4
4 · AZIYO BIOLOGICS, INC. · Filed Mar 9, 2023
Insider Transaction Report
Form 4
Englese Thomas
Chief Commercial Officer
Transactions
- Sale
Class A Common Stock
2023-03-09$4.30/sh−289$1,243→ 17,917 total - Exercise/Conversion
Restricted Stock Units
2023-03-08−937→ 1,875 total→ Class A Common Stock (937 underlying) - Exercise/Conversion
Class A Common Stock
2023-03-08+937→ 18,206 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of the restricted stock units ("RSUs").
- [F2]Represents shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
- [F3]On March 8, 2021, the Reporting Person was granted 3,750 RSUs, vesting in four substantially equal annual installments beginning on March 8, 2022.